M30: A neoepitope in cytokeratin 18 (CK18),
termed M30 neoantigen, becomes available at an early
caspase cleavage event during apoptosis of epitheliumderived
cells, and is not detectable in vital or necrotic
epithelial cells. A monoclonal antibody, M30, specifically
recognizes a fragment of CK18 cleaved at Asp396 (M30
neoantigen) (Figure 8).[56] M30 antibody is specific to
this CK18 cleavage site and does not react with viable